Vivesto presents new Paccal Vet survival and safety data from dog hemangiosarcoma pilot study at VCS 2026
Vivesto flagged newly reported topline results from two Paccal Vet studies for presentation at the Veterinary Cancer Society conference on Sept. 24. Dog pilot study in splenic hemangiosarcoma showed supportive survival and safety outcomes, reinforcing the case to move into a pivotal trial. Cat dose-escalation study ind